The serine/threonine kinase (AKT) signaling pathway is activated via phosphorylation, leading to the cell growth, proliferation, survival, and activation of glucose metabolism, while AKT signaling pathway mutations, especially in PI3KCA and PTEN, are associated with a resistance to hormonal treatment in BC patients [214]. The gene discussed is AKT1; the disease is breast cancer.